Literature DB >> 6148857

Influence of aminasine on experimental scrapie in mice.

V M Roikhel, G I Fokina, V V Pogodina.   

Abstract

The influence of long-term treatment with aminasine--an inhibitor of monoamine oxidase--on duration of the incubation period, morbidity and on accumulation of the agent in the brain was followed in experimental scrapie of mice. Aminasine administration after intracerebral (i.c.) but not after intraperitoneal (i.p.) inoculation of the agent markedly prolonged the incubation period and slightly reduced the morbidity. The accumulation of the scrapie agent and the degree of histological lesions in the CNS detected 6 months post-inoculation (p.i.) were equal in both groups compared. The significance of these results is discussed from the viewpoint of the role of biogenic monoamines in the pathogenesis of scrapie.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148857

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  4 in total

1.  Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease.

Authors:  C Korth; B C May; F E Cohen; S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

2.  Tetracyclines affect prion infectivity.

Authors:  Gianluigi Forloni; Selina Iussich; Tazeen Awan; Laura Colombo; Nadia Angeretti; Laura Girola; Ilaria Bertani; Giorgio Poli; Maria Caramelli; Maria Grazia Bruzzone; Laura Farina; Lucia Limido; Giacomina Rossi; Giorgio Giaccone; James W Ironside; Orso Bugiani; Mario Salmona; Fabrizio Tagliavini
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

Review 3.  Recent advances in prion chemotherapeutics.

Authors:  Valerie L Sim; Byron Caughey
Journal:  Infect Disord Drug Targets       Date:  2009-02

4.  An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein.

Authors:  Claudia Stincardini; Tania Massignan; Silvia Biggi; Saioa R Elezgarai; Valeria Sangiovanni; Ilaria Vanni; Michael Pancher; Valentina Adami; Jorge Moreno; Matteo Stravalaci; Giulia Maietta; Marco Gobbi; Alessandro Negro; Jesús R Requena; Joaquín Castilla; Romolo Nonno; Emiliano Biasini
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.